Although it won’t see the memorials and centenary events that the World War I Armistice will, it’s worth thinking back to the ravages of the ‘Spanish flu’ of a century ago and the implications that that pandemic of the past has for infections of the future.
Another disease in the tropics has the World Health Organisation in a lather, and again biomedicine’s response will not be all that useful in the short term. Social science can help now to address the underlying problems that help the Zika virus to spread — if policymakers will listen.
Bully for the researchers who have developed a vaccine can build resistance against some instances of malaria, says Robert Dingwall. But before the WHO recommends for its adoption, he suggests a harder look at user-centered design and cost-benefit analysis may be in order.
A new report from the World Health Organization on the response to the African Ebola outbreak backs up what our Robert Dingwall has been writing all along — by downplaying social science lives have been lost. The question now is whether a new WHO can improve.
There is no point in improving the innovation pipeline for antibiotics, argues Robert Dingwall, if the drugs that come out at the end all fall into the same chaotic patterns of use as today.
There is a genuine cost from ignoring lessons from social science in the fight against Ebola. What’s even sadder — these lessons were taught in blood three decades ago in the fights against AIDS. Are we ready for the next malady?
WHO is supposed to be a global health organization, not a global biomedical organization. The Ebola crisis, argues Robert Dingwall, reveals the extent to which it has lost sight of this mission.
